EUVIMED · CrossrefJournal
Thoracic Cancer
ISSN 1759-7706 · Wiley
Latest articles
Issue Information
Disparities in Treatment Patterns for Advanced ALK ‐ and EGFR ‐Mutated Non‐Small Cell Lung Cancer Patients in Mexico
Prognostic Value of Early Dynamic Changes in Skeletal Muscle Index for Unresectable Lung Squamous Cell Carcinoma: A Prospective Landmark Analysis
Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report
Correction to “Perioperative Outcomes of Robotic‐Assisted Versus Video‐Assisted Thoracoscopic Lobectomy: A Propensity Score Matched Analysis”
Integrating Machine Learning to Identify Prognostic Subtypes and the Cisplatin Resistance Gene RRM2 in Lung Adenocarcinoma
Preoperative Temporal Elevation of Cytokeratin 19 Fragment in Thymoma With Extensive Necrosis: A Case Report
Predicting for Malignancy in Congenital Lung Malformations: A Single‐Center Study of the “At Risk” Pediatric and Adult Population
Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity
Protocol of a Real‐World Prospective Observational Study of Amivantamab Plus Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Non‐Small Cell Lung Cancer ( SPIRAL ‐ RACER20 Study)
Transesophageal Endoscopic Ultrasound With Bronchoscope‐Guided Fine‐Needle Aspiration for Tissue Diagnosis of Pleural Malignancy in a Patient With Respiratory Compromise
Issue Information
KRAS G12S Positive Non‐Small Cell Lung Cancer Mimicking KRAS G12C Positivity on the AmoyDx PCR Panel: A Case Report
Correction to “Clinical and Imaging Characteristics in the Diagnosis and Surgical Management of Nipple Discharge Without Clinically Palpable Masses: A Retrospective Cohort Study”
Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS ‐Lung 003 Study, Branch Number 28
Clinicopathological Features of DLL3 Expression and T‐Cell Infiltration in LCNEC : Insights From Pathology and Clinical Response to Tarlatamab
Nodule Dye‐Localization Using Interventional Fluoroscopy for Image‐Guided Sublobar Lung Resection
Efficacy and Safety of Trilaciclib for the Prevention of Chemotherapy‐Induced Myelosuppression in Patients With Solid Tumors: A Systematic Review and Meta‐Analysis
Exhaled Breath Analysis for Lung Cancer Detection: From VOCs Signatures to EBC ‐Based Liquid Biopsy and Clinical Translation
SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib
Perioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta‐Analysis
Matrine Suppresses Lung Cancer Progression via Dual Inhibition of CHEK1 ‐Mediated DNA Damage Repair and PI3K / AKT Survival Signaling
Issue Information
ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib‐Treated NSCLC
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2 ‐Positive Metastatic Breast Cancer: A Single‐Center Pooled Analysis
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018–2022: A Nationwide Analysis in Japan
A Noncanonical MET Exon 14 Splice‐Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
Issue Information
Issue Information
EUVIMED